|
US5830702A
(en)
|
1990-10-31 |
1998-11-03 |
The Trustees Of The University Of Pennsylvania |
Live, recombinant listeria monocytogenes and production of cytotoxic T-cell response
|
|
US7662396B2
(en)
|
2001-03-26 |
2010-02-16 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for enhancing the immunogenicity of antigens
|
|
US20070264279A1
(en)
*
|
1994-11-08 |
2007-11-15 |
Claudia Gravekamp |
Compositions and methods comprising a MAGE-b antigen
|
|
US8956621B2
(en)
|
1994-11-08 |
2015-02-17 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for treatment of cervical dysplasia
|
|
US6051237A
(en)
|
1994-11-08 |
2000-04-18 |
The Trustees Of The University Of Pennsylvania |
Specific immunotherapy of cancer using a live recombinant bacterial vaccine vector
|
|
US8114414B2
(en)
|
1994-11-08 |
2012-02-14 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for treatment of cervical cancer
|
|
US7820180B2
(en)
|
2004-09-24 |
2010-10-26 |
The Trustees Of The University Of Pennsylvania |
Listeria-based and LLO-based vaccines
|
|
US7794729B2
(en)
*
|
1994-11-08 |
2010-09-14 |
The Trustees Of The University Of Pennsylvania |
Methods and compositions for immunotherapy of cancer
|
|
US8791237B2
(en)
|
1994-11-08 |
2014-07-29 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for treatment of non-hodgkins lymphoma
|
|
US6099848A
(en)
|
1997-11-18 |
2000-08-08 |
The Trustees Of The University Of Pennsylvania |
Immunogenic compositions comprising DAL/DAT double-mutant, auxotrophic, attenuated strains of Listeria and their methods of use
|
|
US9012141B2
(en)
|
2000-03-27 |
2015-04-21 |
Advaxis, Inc. |
Compositions and methods comprising KLK3 of FOLH1 antigen
|
|
US6855320B2
(en)
|
2000-03-29 |
2005-02-15 |
The Trustees Of The University Of Pennsylvania |
Fusion of non-hemolytic, truncated form of listeriolysin O to antigens to enhance immunogenicity
|
|
JP2004500405A
(ja)
|
2000-03-29 |
2004-01-08 |
ザ トラスティーズ オブ ザ ユニバーシティー オブ ペンシルヴァニア |
抗原の免疫原性を増強するための組成物および方法
|
|
US7700344B2
(en)
|
2001-03-26 |
2010-04-20 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for enhancing the immunogenicity of antigens
|
|
US8771702B2
(en)
|
2001-03-26 |
2014-07-08 |
The Trustees Of The University Of Pennsylvania |
Non-hemolytic LLO fusion proteins and methods of utilizing same
|
|
JP2005527240A
(ja)
|
2002-05-29 |
2005-09-15 |
ザ・レジェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア |
弱毒リステリア種とこれを使用する方法
|
|
AU2004204751A1
(en)
|
2003-01-09 |
2004-07-29 |
The Trustees Of The University Of Pennsylvania |
Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector
|
|
US7855064B2
(en)
|
2004-08-13 |
2010-12-21 |
The Trustees Of The University Of Pennsylvania |
Antibiotic resistance free vaccines and methods for constructing and using same
|
|
AU2005271246A1
(en)
*
|
2004-08-13 |
2006-02-16 |
The Trustees Of The University Of Pennsylvania |
Methods for constructing antibiotic resistance free vaccines
|
|
US7858097B2
(en)
*
|
2004-08-13 |
2010-12-28 |
The Trustees Of The University Of Pennsylvania |
Antibiotic resistance free Listeria strains and methods for constructing and using same
|
|
CA2584130A1
(en)
*
|
2004-10-18 |
2006-04-27 |
Medimmune, Inc. |
High cell density process for growth of listeria
|
|
US7935804B2
(en)
|
2006-03-01 |
2011-05-03 |
Aduro Biotech |
Engineered Listeria and methods of use thereof
|
|
US8268326B2
(en)
|
2006-08-15 |
2012-09-18 |
The Trustees Of The University Of Pennsylvania |
Compositions comprising HMW-MAA and fragments thereof, and methods of use thereof
|
|
EP2977456B1
(en)
|
2006-08-15 |
2017-10-25 |
The Trustees Of The University Of Pennsylvania |
Compositions comprising hmw-maa and fragments thereof for treating cancer
|
|
WO2008130551A2
(en)
|
2007-04-16 |
2008-10-30 |
The Trustees Of The University Of Pennsylvania |
Antibiotic resistance free listeria strains and methods for constructing and using same
|
|
US20140234370A1
(en)
|
2009-11-11 |
2014-08-21 |
Advaxis, Inc. |
Compositions and methods for prevention of escape mutation in the treatment of her2/neu over-expressing tumors
|
|
US9017660B2
(en)
|
2009-11-11 |
2015-04-28 |
Advaxis, Inc. |
Compositions and methods for prevention of escape mutation in the treatment of Her2/neu over-expressing tumors
|
|
EP2853269B1
(en)
|
2008-05-19 |
2019-05-01 |
Advaxis, Inc. |
Dual delivery system for heterologous antigens comprising a recombinant Listeria strain attenuated by mutation of dal/dat and deletion of ActA comprising a nucleic acid molecule encoding an listeriolysin O - prostate specific anigen fusion protein
|
|
US9650639B2
(en)
|
2008-05-19 |
2017-05-16 |
Advaxis, Inc. |
Dual delivery system for heterologous antigens
|
|
CN102076843A
(zh)
*
|
2008-05-19 |
2011-05-25 |
艾杜罗生物科技公司 |
包含prfa*突变体李斯特菌的组合物及其使用方法
|
|
US20120135033A1
(en)
|
2008-05-19 |
2012-05-31 |
Anu Wallecha |
Multiple delivery system for heterologous antigens
|
|
US20150366955A9
(en)
|
2009-11-11 |
2015-12-24 |
Advaxis, Inc. |
Compositions and methods for prevention of escape mutation in the treatment of her2/neu over-expressing tumors
|
|
US20120100170A1
(en)
*
|
2008-07-24 |
2012-04-26 |
Lauer Peter M |
Compositions and methods for the treatment of hepatitis c
|
|
EP2403935B1
(en)
|
2009-03-04 |
2017-05-10 |
The Trustees Of The University Of Pennsylvania |
Compositions comprising angiogenic factors and methods of use thereof
|
|
WO2011060260A2
(en)
|
2009-11-11 |
2011-05-19 |
Advaxis |
Compositions and methods for prevention of escape mutation in the treatment of her2/neu over-expressing tumors
|
|
US10016617B2
(en)
|
2009-11-11 |
2018-07-10 |
The Trustees Of The University Of Pennsylvania |
Combination immuno therapy and radiotherapy for the treatment of Her-2-positive cancers
|
|
US20110223187A1
(en)
|
2010-02-15 |
2011-09-15 |
Vafa Shahabi |
Live listeria-based vaccines for central nervous system therapy
|
|
US20110305724A1
(en)
|
2010-04-19 |
2011-12-15 |
Yvonne Paterson |
Immunotherapeutic, anti-tumorigenic compositions and methods of use thereof
|
|
EP2621527A4
(en)
|
2010-10-01 |
2015-12-09 |
Univ Pennsylvania |
USE OF LISTERIA VACCINE VECTORS TO REVERSE VACCINE IMMUNITY IN PATIENTS WITH PARASITIC INFECTIONS
|
|
DK2640842T3
(en)
|
2010-11-17 |
2018-08-13 |
Aduro Biotech Inc |
Methods and compositions for inducing an immune response to EGFRVIII
|
|
AU2012229218B2
(en)
|
2011-03-11 |
2017-03-02 |
Advaxis, Inc. |
Listeria-based adjuvants
|
|
WO2013138337A1
(en)
|
2012-03-12 |
2013-09-19 |
Advaxis |
Suppressor cell function inhibition following listeria vaccine treatment
|
|
KR20160130774A
(ko)
|
2014-02-18 |
2016-11-14 |
어드박시스, 인크. |
바이오마커 지도된 다중-표적 면역치료
|
|
RU2016137834A
(ru)
|
2014-02-25 |
2018-03-29 |
Адваксис, Инк. |
КОМПОЗИЦИИ И СПОСОБЫ ЛЕЧЕНИЯ ОПУХОЛЕЙ, СВЕРХЭКСПРЕССИРУЮЩИХ HER2/neu
|
|
BR112016020364A2
(pt)
|
2014-03-05 |
2018-01-16 |
Advaxis, Inc. |
métodos para suscitar uma resposta de uma célula t antitumoral em um indivíduo tendo um tumor ou câncer e para aumentar a razão de células t efetoras sobre células t reguladoras no baço de um indivíduo
|
|
SG10202011841WA
(en)
|
2014-04-24 |
2021-01-28 |
Advaxis Inc |
Recombinant listeria vaccine strains and methods of producing the same
|
|
CN106794234A
(zh)
|
2014-05-02 |
2017-05-31 |
宾夕法尼亚大学理事会 |
用于治疗her‑2阳性癌症的联合免疫疗法和放疗
|
|
WO2016011320A1
(en)
|
2014-07-18 |
2016-01-21 |
Advaxis, Inc. |
Bivalent listeria-based delivery system of heterologous antigens
|
|
SG11201700092XA
(en)
|
2014-07-18 |
2017-02-27 |
Advaxis Inc |
Recombinant listeria strain expressing heterologous antigen fusion proteins and methods of use thereof
|
|
EP3193921A4
(en)
|
2014-07-18 |
2018-04-25 |
Advaxis, Inc. |
Combination of a pd-1 antagonist and a listeria-based vaccine for treating prostate cancer
|
|
AU2015289449A1
(en)
|
2014-07-18 |
2017-02-09 |
Advaxis, Inc. |
Listeria-based immunogenic compositions for eliciting anti-tumor responses
|
|
JP2017536095A
(ja)
|
2014-10-14 |
2017-12-07 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
組み換え型リステリアワクチン株および癌免疫療法におけるその使用方法
|
|
MA41218A
(fr)
|
2014-12-19 |
2017-10-24 |
Advaxis Inc |
Combinaison de vaccin à base de listeria comportant des anticorps anti-ox40 ou anti-gitr
|
|
US20160220652A1
(en)
|
2015-02-03 |
2016-08-04 |
Advaxis, Inc. |
Methods of using recombinant listeria vaccine strains in disease immunotherapy
|
|
WO2016126878A2
(en)
|
2015-02-03 |
2016-08-11 |
The Trustees Of The University Of Pennsylvania |
Listeria-based immunomodulation
|
|
WO2016126876A2
(en)
|
2015-02-03 |
2016-08-11 |
Advaxis, Inc. |
Listeria-based adjuvants
|
|
MA41644A
(fr)
|
2015-03-03 |
2018-01-09 |
Advaxis Inc |
Compositions à base de listeria comprenant un système d'expression de minigènes codant pour des peptides, et leurs procédés d'utilisation
|
|
WO2016154412A2
(en)
|
2015-03-26 |
2016-09-29 |
The Trustees Of The University Of Pennsylvania |
Combination of a pd-1 antagonist and a listeria based vaccine for treating pancreatic cancer
|
|
US20180104284A1
(en)
|
2015-05-13 |
2018-04-19 |
Advaxis, Inc. |
Immunogenic Listeria-Based Compositions Comprising Truncated Acta-Antigen Fusions And Methods Of Use Thereof
|
|
US20190381160A1
(en)
|
2015-05-26 |
2019-12-19 |
Advaxis, Inc. |
Personalized delivery vector-based immunotherapy and uses thereof
|
|
US20170204361A1
(en)
|
2015-06-24 |
2017-07-20 |
Advaxis, Inc. |
Manufacturing device and process for personalized delivery vector-based immunotherapy
|
|
MA42841A
(fr)
|
2015-09-15 |
2018-07-25 |
Advaxis Inc |
Procédé de fabrication d'une formulation immunothérapeutique comprenant une souche de listeria de recombinaison
|
|
WO2017048850A1
(en)
|
2015-09-15 |
2017-03-23 |
Advaxis, Inc. |
Listeria-based immunogenic compositions and methods of use thereof in cancer prevention and treatment
|
|
CA2998889A1
(en)
|
2015-09-17 |
2017-03-23 |
Advaxis, Inc. |
Recombinant listeria vaccine strains and methods of using the same in cancer immunotherapy
|
|
MA43124A
(fr)
|
2015-10-14 |
2018-09-05 |
Advaxis Inc |
Souches recombinées vaccinales de listeria et leurs méthodes d'utilisation en immunothérapie anticancéreuse
|
|
WO2017085691A1
(en)
|
2015-11-20 |
2017-05-26 |
Advaxis, Inc. |
Manufacturing device and method of an immunotherapeutic formulation comprising a recombinant listeria strain
|
|
WO2017106754A2
(en)
|
2015-12-16 |
2017-06-22 |
Advaxis, Inc. |
Listeria-based immunotherapy and methods of use thereof
|
|
MX2018009225A
(es)
|
2016-01-27 |
2019-08-21 |
Advaxis Inc |
Inmunoterapia basada en vectores de distribución personalizados y usos de la misma.
|
|
CA3029235A1
(en)
|
2016-07-05 |
2018-01-11 |
Advaxis, Inc. |
Listeria-based immunogenic compositions comprising wilms tumor protein antigens and methods of use thereof
|
|
MA46721A
(fr)
|
2016-11-07 |
2019-09-11 |
Advaxis Inc |
Combinaison d'un vaccin à base de listeria avec des anticorps anti-ctla-4 ou anti-cd137
|
|
WO2018102585A1
(en)
|
2016-11-30 |
2018-06-07 |
Advaxis, Inc. |
Personalized immunotherapy in combination with immunotherapy targeting recurrent cancer mutations
|
|
CA3035591A1
(en)
|
2016-11-30 |
2018-06-07 |
Advaxis, Inc. |
Immunogenic compositions targeting recurrent cancer mutations and methods of use thereof
|
|
TW201833323A
(zh)
|
2017-01-05 |
2018-09-16 |
美商艾法西斯公司 |
重組李斯特菌屬疫苗菌株及在癌症免疫治療中使用該菌株之方法
|